Protalix BioTherapeutics Announces New Clinical Data on taliglucerase alfa Presented at the 10th Annual European Working Group on Gaucher Disease Meeting
July 02, 2012 07:30 ET
|
Protox Therapeutics Corporation
CARMIEL, Israel, July 2, 2012 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE-MKT:PLX) (TASE:PLX) announced today that new clinical data on taliglucerase alfa was presented at the 10th Annual...